Recap: Kiniksa Pharmaceuticals Q1 Earnings

Kiniksa Pharmaceuticals KNSA reported its Q1 earnings results on Tuesday, May 3, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Kiniksa Pharmaceuticals beat estimated earnings by 12.2%, reporting an EPS of $-0.36 versus an estimate of $-0.41.

Revenue was up $32.19 million from the same period last year.

Last quarter the company missed on EPS by $0.11 which was followed by a 5.93% drop in the share price the next day.

Here's a look at Kiniksa Pharmaceuticals's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	-0.42	-0.65	-0.79	-0.80
EPS Actual	-0.53	-0.44	-0.61	-0.72
Revenue Estimate	20.72M	10.18M	3.97M	3.72M
Revenue Actual	18.75M	12.10M	7.70M	0

To track all earnings releases for Kiniksa Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar